Evidence map›Paper›PMID 25763817›Full record

ArticlePloS one2015

On the role of protein disulfide isomerase in the retrograde cell transport of secreted phospholipases A2.

Jernej Oberčkal, Lidija Kovačič, Jernej Šribar, Adrijana Leonardi, Klemen Dolinar, Anja Pucer Janež, Igor Križaj

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. What Are the Neurotoxins in Hemotoxic Snake Venoms?International journal of molecular sciences · 2023
    Review
  2. Rat Group IIA Secreted Phospholipase AInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Secreted Phospholipases AInternational journal of biological sciences · 2022
    Review
  5. Review
  6. The neurotoxic secreted phospholipase AScientific reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jernej OberčkalDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Lidija KovačičDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Jernej ŠribarDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Adrijana LeonardiDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Klemen DolinarDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Anja Pucer JanežDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia.
Igor KrižajDepartment of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia; Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
Jožef Stefan Institute · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the finding that ammodytoxin (Atx), a neurotoxic secreted phospholipase A2 (sPLA2) in snake venom, binds specifically to protein disulfide isomerase (PDI) in vitro we show that these proteins also interact in living rat PC12 cells that are able to internalize this group IIA (GIIA) sPLA2. Atx and PDI co-localize in both differentiated and non-differentiated PC12 cells, as shown by fluorescence microscopy. Based on a model of the complex between Atx and yeast PDI (yPDI), a three-dimensional model of the complex between Atx and human PDI (hPDI) was constructed. The Atx binding site on hPDI is situated between domains b and b'. Atx interacts hPDI with an extensive area on its interfacial binding surface. The mammalian GIB, GIIA, GV and GX sPLA2s have the same fold as Atx. The first three sPLA2s have been detected intracellularly but not the last one. The models of their complexes with hPDI were constructed by replacement of Atx with the respective mammalian sPLA2 in the Atx-hPDI complex and molecular docking of the structures. According to the generated models, mammalian GIB, GIIA and GV sPLA2s form complexes with hPDI very similar to that with Atx. The contact area between GX sPLA2 and hPDI is however different from that of the other sPLA2s. Heterologous competition of Atx binding to hPDI with GV and GX sPLA2s confirmed the model-based expectation that GV sPLA2 was a more effective inhibitor than GX sPLA2, thus validating our model. The results suggest a role of hPDI in the (patho)physiology of some snake venom and mammalian sPLA2s by assisting the retrograde transport of these molecules from the cell surface. The sPLA2-hPDI model constitutes a valuable tool to facilitate further insights into this process and into the (patho)physiology of sPLA2s in relation to their action intracellularly.

Indexed as

AnimalsMolecular Docking SimulationPC12 CellsPhospholipases A2, SecretoryProtein BindingProtein ConformationProtein Disulfide-IsomerasesProtein TransportRatsPhospholipases A2, SecretoryProtein Disulfide-Isomerases

Identifiers

PMID25763817
PMCPMC4357439
OpenAlexW2152420868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.